Company Profile
Yangzhou winsome aba pharmacy Co.,Ltd. is a production and sales enterprise encompassing chemical synthesis, contract processing and new products research and development. It is one of the current doxycycline series manufacturers with world largest output. The company is located in the scenery beautiful China historical city Yangzhou eastern suburb, the Yangtze River golden shore, the Jiangsu provincial level development zone ------ Jiangdu economy development zone, factory district surrounded by water, environment exquisite, geographical position superior, path direct Beijing and Shanghai, Shanghai and Nanjing, rather pass high speed, also is rather opens the railroad the important stand, the amphibious transportation is extremely convenient. Yangzhou winsome aba pharmacy Co.,Ltd. covers an area of 55,000 square meters and 21,000 square meters for floor space. The company has 326 employees including engineers and technicians accounting for above 30%. New-built production base covers an areas of 70,000 square meters. The company passed National GMP authentication in 2004 and ISO 9001, ISO14000 and ISO18000 management system authentication in 2006. It is the Jiangsu Province high technology and new technology enterprise; the banking rating is the AAA level. For assorting big international group, the company will gradually move raw materials and intermediate production process to the Asia. In years, the company has set up two R&D centers in Shanghai, and has developed, synthesized, customized and processed chemical materials, intermediates and chiral compounds for multi-national enterprises. Yangzhou winsome aba pharmacy Co.,Ltd. creates a experienced employee team who has quality management, production management and R&D of new products. The company mainly produces and sells hydrochloric acid doxycycline series products, Venlafaxine Hydrochloride, intermediates and processing business of international multi-national enterprises. For years, the company has won good trust from new and old customers depending on better product quality and good service in Europe, America, Middle East, Asia and others. We always take the tenet of safety and environmental-protection first, product quality top, customer as center and pursing better. The company is dedicating to development, research, production and custom process and provides services for more international multi-national enterprises depending on strong research and development ability.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(1-Hydroxycyclohexyl)(4-methoxyphenyl)acetonitrile |
Benzeneacetonitrile,α-(1-hydroxycyclohexyl)-4-methoxy-;Benzeneacetonitrile,α-(1-hydroxycyclohexyl)-4-methoxy-,(±)-;α-(1-Hydroxycyclohexyl)-4-methoxybenzeneacetonitrile;1-[Cyano(4-methoxyphenyl)methyl]cyclohexanol;α-(p-Methoxyphenyl)-α-(1-hydroxycyclohexyl)acetonitrile;1-[Cyano(p-methoxyphenyl)methyl]cyclohexanol;(4-Methoxyphenyl)-(1-hydroxycyclohex-1-yl)acetonitrile;2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile;131801-69-9;300827-97-8;606928-54-5 |
93413-76-4 | Inquiry | |
Cbz-L-tert-Leucine |
2S-BenzyloxycarbonylaMino-3,3-diMethylbutyric Acid;3-Methyl-N-[(phenylMethoxy)carbonyl]-L-valine;Benzyloxycarbonyl-L-tert-leucine;N-(Benzyloxycarbonyl)-L-tert-butylglycine;N-Benzyloxycarbonyl-tert-leucine;N-Carbobenzoxy-(S)-tert-leucine;(S)-2-(((Benzyloxy)carbonyl)aMino)-3,3-diMethylbutanoic acid;(2S)-2-([(Benzyloxy)Carbonyl]AMino)-3,3-DiMethylbutanoic Acid DicyclohexylaMine Salt |
62965-10-0 | Inquiry | |
Doxycycline hyclate |
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride,(4S,4aR,5S,5aR,6R,12aS)-,compd. with ethanol,hydrate (2:2:1:1);2-Naphthacenecarboxamide,4β-(dimethylamino)-1,4,4aβ,5,5aβ,6,11,12a-octahydro-3,5β,10,12,12aβ-pentahydroxy-6β-methyl-1,11-dioxo-,monohydrochloride,compd. with ethyl alc. (2:1),monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,[4S-(4α,4aα,5α,5aα,6α,12aα)]-,compd. with ethanol (2:1),monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-,compd. with ethanol (2:1),monohydrate;Ethanol,compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2),monohydrate;Ethanol,compd. with (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2),monohydrate;Doxycycline hydrochloride hemiethanolate hemihydrate;Doxycycline hyclate;6-Desoxy-5-hydroxytetracycline hydrochloride hemihydrate hemiethanolate;Atridox;Periostat;Monodoks;Tetraclean;BioPure MTAD;62149-53-5;1258072-64-8 |
24390-14-5 | Inquiry | |
doxycycline monohydrate |
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1),(4S,4aR,5S,5aR,6R,12aS)-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrate,[4S-(4α,4aα,5α,5aα,6α,12aα)]-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrate,(4S,4aR,5S,5aR,6R,12aS)-;6-Deoxy-5-oxytetracycline monohydrate;Doxycycline monohydrate;Oracea;Vibravet;Doxyhexal;1397200-45-1 |
17086-28-1 | Inquiry | |
Fmoc-L-alpha-t-butylglycine |
FMOC-L-TLE-OH;FMOC-L-T-BUTYLGLYCINE;FMOC-L-TERT-LEUCINE;FMOC-TLE-OH;FMOC-TBU-GLYCINE;FMOC-TBU-GLY-OH;FMOC-ALPHA-T-BUTYL-GLY-OH;FMOC-ALPHA-T-BUTYLGLYCINE |
132684-60-7 | Inquiry | |
L-tert-Leucine |
L-Valine,3-methyl-;Butyric acid,2-amino-3,3-dimethyl-,L-;3-Methyl-L-valine;L-tert-Leucine;β-Methyl-L-valine;L-Pseudoleucine;(S)-tert-Leucine;L-2-Amino-3,3-dimethylbutyric acid;tert-L-Leucine;(S)-tert-Butylglycine;L-tert-Butylglycine;(2S)-2-Amino-3,3-dimethylbutanoic acid;(S)-2-Amino-3,3-dimethylbutyric acid;NSC 203785;tert-Butyl-L-glycine;(S)-2-Amino-3,3-dimethylbutanoic acid |
20859-02-3 | Inquiry | |
L-tert-Leucine methyl ester hydrochloride |
L-Valine,3-methyl-,methyl ester,hydrochloride (1:1);L-Valine,3-methyl-,methyl ester,hydrochloride;L-tert-Leucine methyl ester hydrochloride;Methyl (2S)-2-amino-3,3-dimethylbutanoate hydrochloride;Methyl (S)-2-amino-3,3-dimethylbutanoate hydrochloride;L-tert-Butylglycine methyl ester hydrochloride |
63038-27-7 | Inquiry | |
Metacycline hydrochloride |
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-,hydrochloride (1:1),(4S,4aR,5S,5aR,12aS)-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-,monohydrochloride;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-,monohydrochloride,[4S-(4α,4aα,5α,5aα,12aα)]-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,12aS)-;6-Demethyl-6-deoxy-6-methyleneoxytetracycline monohydrochloride;Methacycline monohydrochloride;Methacycline hydrochloride;6-Methylene-5-hydroxytetracycline chlorohydrate;6-Methylene-5-hydroxytetracycline hydrochloride;6-Demethyl-6-deoxy-6-methylene-5-hydroxytetracycline hydrochloride;Metacycline hydrochloride;6-Methyleneoxytetracycline hydrochloride;6-Demethyl-6-deoxy-5-hydroxy-6-methylenetetracycline hydrochloride;Metacyclin hydrochloride;Rindex;Adriamicina;Physiomycine;Metilenbiotic;Metadomus;Ciclobiotic;Londomycin;Germiciclin;Optimycin;101813-12-1;2507-30-4;60080-37-7;857212-11-4 |
3963-95-9 | Inquiry |